jin medical international ltd - ZJYL

ZJYL

Close Chg Chg %
2.38 -0.09 -3.60%

Open Market

2.29

-0.09 (3.60%)

Volume: 1.84K

Last Updated:

May 26, 2026, 11:37 AM EDT

Company Overview: jin medical international ltd - ZJYL

ZJYL Key Data

Open

$2.39

Day Range

2.28 - 2.39

52 Week Range

1.64 - 17.18

Market Cap

$18.63M

Shares Outstanding

7.83M

Public Float

1.83M

Beta

7.53

Rev. Per Employee

N/A

P/E Ratio

15.61

EPS

N/A

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

8.49K

 

ZJYL Performance

1 Week
 
0.00%
 
1 Month
 
9.98%
 
3 Months
 
-18.14%
 
1 Year
 
-84.86%
 
5 Years
 
N/A
 

ZJYL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About jin medical international ltd - ZJYL

Jin Medical International Ltd. is a holding company. It is engaged in the design, development, manufacturing, and sale of wheelchair and other living aids products to be used by people with disabilities or impaired mobility. The company was founded on January 14, 2020 and is headquartered in Changzhou, China.

ZJYL At a Glance

Jin Medical International Ltd.
33 Lingxiang Road
Changzhou, Jiangsu
Phone 86-519-89607972 Revenue 20.69M
Industry Medical Specialties Net Income 1.19M
Sector Health Technology Employees 295
Fiscal Year-end 09 / 2026
View SEC Filings

ZJYL Valuation

P/E Current 15.608
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 74.244
Price to Sales Ratio 4.276
Price to Book Ratio 2.984
Price to Cash Flow Ratio 30.46
Enterprise Value to EBITDA 82.812
Enterprise Value to Sales 3.734
Total Debt to Enterprise Value 0.239

ZJYL Efficiency

Revenue/Employee 70,126.353
Income Per Employee 4,038.295
Receivables Turnover 3.041
Total Asset Turnover 0.417

ZJYL Liquidity

Current Ratio 1.851
Quick Ratio 1.559
Cash Ratio 1.245

ZJYL Profitability

Gross Margin 29.219
Operating Margin 2.94
Pretax Margin 7.714
Net Margin 5.759
Return on Assets 2.403
Return on Equity 4.076
Return on Total Capital 2.475
Return on Invested Capital 4.069

ZJYL Capital Structure

Total Debt to Total Equity 62.415
Total Debt to Total Capital 38.429
Total Debt to Total Assets 34.663
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital N/A
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Jin Medical International Ltd - ZJYL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
19.19M 19.82M 23.50M 20.69M
Sales Growth
-7.58% +3.29% +18.57% -11.98%
Cost of Goods Sold (COGS) incl D&A
12.99M 13.04M 14.00M 14.64M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
357.27K 220.95K 328.22K 324.68K
Depreciation
357.27K 220.95K 328.22K 324.68K
Amortization of Intangibles
- - - -
-
COGS Growth
-9.80% +0.34% +7.38% +4.60%
Gross Income
6.20M 6.78M 9.50M 6.04M
Gross Income Growth
-2.56% +9.46% +40.06% -36.39%
Gross Profit Margin
+32.30% +34.23% +40.43% +29.22%
2022 2023 2024 2025 5-year trend
SG&A Expense
4.07M 3.92M 5.86M 5.44M
Research & Development
1.89M 1.54M 1.50M 1.56M
Other SG&A
2.18M 2.37M 4.37M 3.88M
SGA Growth
+9.07% -3.70% +49.69% -7.29%
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
2.13M 2.87M 3.64M 608.18K
Non Operating Income/Expense
612.12K 354.67K 544.96K 987.64K
Non-Operating Interest Income
181.61K 182.68K 466.52K 789.07K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - -
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - -
-
Interest Capitalized
- - - -
-
Pretax Income
2.74M 3.22M 4.18M 1.60M
Pretax Income Growth
-4.78% +17.48% +29.85% -61.86%
Pretax Margin
+14.29% +16.25% +17.80% +7.71%
Income Tax
36.11K 343.71K 763.88K 214.57K
Income Tax - Current - Domestic
122.13K 254.11K 727.55K 236.64K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(86.02K) 89.60K 36.33K (22.07K)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.71M 2.88M 3.42M 1.38M
Minority Interest Expense
- - (256.09K) 189.95K
-
Net Income
2.71M 2.88M 3.68M 1.19M
Net Income Growth
+2.84% +6.34% +27.71% -67.59%
Net Margin Growth
+14.10% +14.52% +15.64% +5.76%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.71M 2.88M 3.68M 1.19M
Preferred Dividends
- - - -
-
Net Income Available to Common
2.71M 2.88M 3.68M 1.19M
EPS (Basic)
0.3383 0.3966 0.4696 0.1522
EPS (Basic) Growth
+2.83% +17.23% +18.41% -67.59%
Basic Shares Outstanding
8.00M 7.26M 7.83M 7.83M
EPS (Diluted)
0.3383 0.3954 0.4696 0.1522
EPS (Diluted) Growth
+2.83% +16.88% +18.77% -67.59%
Diluted Shares Outstanding
8.00M 7.28M 7.83M 7.83M
EBITDA
2.49M 3.09M 3.97M 932.86K
EBITDA Growth
-16.31% +24.13% +28.46% -76.48%
EBITDA Margin
+12.96% +15.58% +16.88% +4.51%

Jin Medical International Ltd in the News